Detailed Quote
5i Report
Rating
B
Review of Vitalhub Corp.
JUN 13, 2024 - VHI operates as a technology service provider to the Health and Human Services sector. The company’s offerings mainly serve the digital health solutions market focusing on acute hospital, mental health, community and social services sectors. VHI is another interesting, high-quality serial acquirer in the making. There is some risk of dilution with the aggressive growth that VHI is pursuing which involves share issuance to fund acquisitions. Rating initiated at a ‘B’.
Download ReportCompany Profile
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
Q: Hi, thinking of adding a small position in one of these to add some torque within an RSP. Which one would you choose right ow and what price would you recommend buying at? Thanks
Q: Hi Team,
Out of HPS.A and VHI, which do you like better today? Looking for highest potential return over the next 10 years.
Thanks,
Shane.
Out of HPS.A and VHI, which do you like better today? Looking for highest potential return over the next 10 years.
Thanks,
Shane.
Q: Hi team,
What’s your current thoughts on Vhi? Valuation wise it currently seems pricey . But , the company recently completed a big offering at near today’s price. So, investors seem to want to pay up for the name. Recently Jason Donville named it as a top pick , with him spouting that it should be a $20 stock in a year. Is this realistic ? I remember when Donville was a small cap god on BNN 10 years ago; at one time he had a good reputation it seemed as a stock picker . He also mentioned that it is the next dsg. Big shoes to full. I guess question is does vhi really have the potential to change the healthcare software sector radically in the next few years ? Does it hold a product ahead of any competition? Is this a name that could be a huge winner in the long run ? I hold a smaller position currently. Wondering if it’s worth a shot adding to the band long term at this level ?
Thanks ,
Shane
What’s your current thoughts on Vhi? Valuation wise it currently seems pricey . But , the company recently completed a big offering at near today’s price. So, investors seem to want to pay up for the name. Recently Jason Donville named it as a top pick , with him spouting that it should be a $20 stock in a year. Is this realistic ? I remember when Donville was a small cap god on BNN 10 years ago; at one time he had a good reputation it seemed as a stock picker . He also mentioned that it is the next dsg. Big shoes to full. I guess question is does vhi really have the potential to change the healthcare software sector radically in the next few years ? Does it hold a product ahead of any competition? Is this a name that could be a huge winner in the long run ? I hold a smaller position currently. Wondering if it’s worth a shot adding to the band long term at this level ?
Thanks ,
Shane
Insiders
Share Information
News and Media